PHARMACY

Chiesi Farmaceutici S.p.A. acquires specialty pharmaceutical company Cornerstone Therapeutics

BY Michael Johnsen

CARY, N.C. — Cornerstone Therapeutics, a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets, on Monday announced that its stockholders have approved, at a special stockholder meeting, the previously announced merger agreement, under which Chiesi Farmaceutici S.p.A. will acquire all of the outstanding common shares of Cornerstone for $9.50 per share in cash.

Votes for the adoption of the merger agreement totaled approximately 22.5 million shares, or 83.7% of Cornerstone’s outstanding shares of common stock. 

Approximately 4.4 million shares, or 50.2% of the shares not owned by Chiesi or any of its subsidiaries or by any officer or director of Cornerstone, voted for the merger.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

PhRMA partners with NIH on drug development

BY Michael Johnsen

WASHINGTON — The Pharmaceutical Research and Manufacturers of America on Tuesday announced a partnership with the National Institutes of Health that will help spur drug development, the association stated. 

The Accelerating Medicines Partnership — an initiative of NIH, several non-profit disease foundations, 10 biopharmaceutical companies and PhRMA — aims to transform the current model for developing new diagnostics and treatments by joining forces to identify and validate promising biological targets of disease. 

AMP represents a new, integrated approach to treatment discovery and seeks to increase the number of new diagnostics and therapies for patients while reducing the time and cost associated with their development. The initiative will begin with three- to five-year pilot projects focused on three disease areas: Alzheimer’s, Type 2 diabetes and autoimmune disorders, including rheumatoid arthritis and lupus. AMP data and analyses will be publicly accessible to the biomedical community.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Walgreens offers free blood-pressure testing in support of American Heart Month

BY Michael Johnsen

DEERFIELD, Ill. — In support of American Heart Month, Walgreens is offering free blood-pressure testing at all of its pharmacies and Healthcare Clinics throughout the month of February, the retailer announced Monday.

Tests are available daily during pharmacy and clinic hours with no appointment necessary and are administered by Walgreens pharmacists and Healthcare Clinic nurse practitioners and physician assistants. The free testing aims to encourage customers to know the two critical numbers that can inspire prevention or treatment of hypertension, a disease that often presents no symptoms, but increases the risk for heart disease and stroke.

"Regular health testing is one of the best ways for people to manage their health, and when it comes to blood pressure, it’s important for people to know their numbers because detection of high blood pressure can be critical," stated Harry Leider, Walgreens chief medical officer. "Our pharmacists and Healthcare Clinic nurse practitioners and physician assistants are an accessible community resource providing free blood-pressure testing throughout the month as part of Walgreens commitment to help people get, stay and live well."

Tests are not done for diagnostic or treatment purposes, and individuals are advised to share their test results with their primary care physician.

Blood pressure trackers, designed to help customers monitor their numbers over time, and American Heart Association educational materials also are available through the pharmacy. Additionally, customers have the option to support the American Heart Association by providing a donation at checkout.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?